BRIEF-Cognition Therapeutics Announces All Participants Have Completed Their Final Visits

Reuters11-26

BRIEF-Cognition <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Announces All Participants Have Completed Their Final Visits

Nov 26 (Reuters) - Cognition Therapeutics Inc CGTX.O:

COGNITION THERAPEUTICS ANNOUNCES ALL PARTICIPANTS HAVE COMPLETED THEIR FINAL VISITS IN THE PHASE 2 SHIMMER STUDY OF CT1812 IN DEMENTIA WITH LEWY BODIES
COGNITION THERAPEUTICS INC -TOPLINE RESULTS IN SECOND DEMENTIA INDICATION EXPECTED TO BE REPORTED IN DECEMBER 2024

Source text: ID:nGNX7N8MYJ

Further company coverage: CGTX.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2486379072?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-26 20:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2486379072","market":"us","top_or_hot":-1,"title":"BRIEF-Cognition Therapeutics Announces All Participants Have Completed Their Final Visits","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Cognition <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Announces All Participants Have Completed Their Final Visits</title></head><body><p><span>Nov 26 (Reuters)</span><span> - </span>Cognition Therapeutics Inc <span>CGTX.O</span>:</p><ul><li><p>COGNITION THERAPEUTICS ANNOUNCES ALL PARTICIPANTS HAVE COMPLETED THEIR FINAL VISITS IN THE PHASE 2 SHIMMER STUDY OF CT1812 IN DEMENTIA WITH LEWY BODIES</p></li><li><p>COGNITION THERAPEUTICS INC -TOPLINE RESULTS IN SECOND DEMENTIA INDICATION EXPECTED TO BE REPORTED IN DECEMBER 2024</p></li></ul><p>Source text: <span>ID:nGNX7N8MYJ</span></p><p>Further company coverage: <span>CGTX.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Cognition Therapeutics Announces All Participants Have Completed Their Final Visits</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Cognition Therapeutics Announces All Participants Have Completed Their Final Visits\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-26 20:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241126:nTUA1LKF3J:1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BRIEF-Cognition Therapeutics Announces All Participants Have Completed Their Final VisitsNov 26 (Reuters) - Cognition Therapeutics Inc CGTX.O:COGNITION THERAPEUTICS ANNOUNCES ALL PARTICIPANTS HAVE ...</p>\n\n<a href=\"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241126:nTUA1LKF3J:1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CGTX","symbol_name":"Cognition Therapeutics, Inc","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241126:nTUA1LKF3J:1","article_id":"2486379072","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2486379072","pubTimestamp":1732625196,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Cognition Therapeutics Announces All Participants Have Completed Their Final VisitsNov 26 (Reuters) - Cognition Therapeutics Inc CGTX.O:COGNITION THERAPEUTICS ANNOUNCES ALL PARTICIPANTS HAVE COM","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CGTX":"Cognition Therapeutics, Inc","BK4007":"制药"},"translate_title":"简介-Cognition Therapeutics宣布所有参与者均已完成最终访视","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CGTX":0.9},"content_text":"BRIEF-Cognition Therapeutics Announces All Participants Have Completed Their Final VisitsNov 26 (Reuters) - Cognition Therapeutics Inc CGTX.O:COGNITION THERAPEUTICS ANNOUNCES ALL PARTICIPANTS HAVE COMPLETED THEIR FINAL VISITS IN THE PHASE 2 SHIMMER STUDY OF CT1812 IN DEMENTIA WITH LEWY BODIESCOGNITION THERAPEUTICS INC -TOPLINE RESULTS IN SECOND DEMENTIA INDICATION EXPECTED TO BE REPORTED IN DECEMBER 2024Source text: ID:nGNX7N8MYJFurther company coverage: CGTX.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2486379072"}